Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Diseas
A study to identify patients with Rheumatoid Arthritis - Associated Interstitial Lung Disease (RA-ILD) that are at the highest risk for progression. The goal of the investigators is to recruit a group of patients with RA-ILD and collect information to help us understand more about disease progression. The investigators
| Condition(s) | Rheumatoid Arthritis, Interstitial Lung Disease |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | A study to identify patients with Rheumatoid Arthritis - Associated Interstitial Lung Disease (RA-ILD) that are at the highest risk for progression. The goal of the investigators is to recruit a group of patients with RA-ILD and collect information to help us understand more about disease progression. The investigators will do this using a combination of clinical, radiologic, and biologic features. |
| Who can participate | Inclusion Criteria: * Multidisciplinary diagnosis of RA-ILD based on the 2010 American College of Rheumatology criteria * 18 years of age or older Exclusion Criteria: * Prior medication treatment specifically for RA-ILD * Inability to give informed consent * Pregnant women |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Lead sponsor | University of Colorado, Denver |
| Locations | San Francisco, California, United States; Aurora, Colorado, United States; Kansas City, Kansas, United States; Ann Arbor, Michigan, United States |
| Start date | 2024-01-22 |
| NCT ID | NCT06397677 |
| Official listing | https://clinicaltrials.gov/study/NCT06397677 |